UnitedHealthcare Specialty Benefits (UHSB) has extended coverage for Zila's ViziLite Plus, a screening device for the early detection of oral abnormalities that could lead to cancer.
"With UnitedHealthcare Specialty Benefits making oral cancer screening with ViziLite Plus a benefit, more than 21 million lives are now covered," said David Bethune, chairman and chief executive officer of Zila. "UHSB is joining a growing list of premier national insurance plans that provide coverage for ViziLite Plus, including Cigna, Humana, Guardian, and Safeguard, as well as a number of regional plans and self-insured employers."
The company believes insurance providers are extending coverage of ViziLite Plus because early cancer detection leads to improved health outcomes for patients and lower overall medical costs, he added.
